I-Imatinib Mesylate CAS 220127-57-1 Assay 98.0% ~ 102.0% Ph+CML API Factory High Quality
Ubonelelo ngezoRhwebo i-Imatinib Mesylate kunye nabaPhakathi abaNxulumeneyo:
I-Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS: 106261-49-8
Igama leMchiza | I-Imatinib Mesylate (ifomu yealpha) |
Izithethantonye | I-Imatinib Methanesulfonate;STI571 Mesylate;CGP-57148B |
Inombolo yeCAS | 220127-57-1 |
Inombolo yeCAT | RF-API19 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C30H35N7O4S |
Ubunzima beMolekyuli | 589.71 |
Imeko yokuthumela ngenqanawa | Phantsi koBubushushu be-Ambient |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder |
Ukunyibilika | Kulula ukunyibilika emanzini |
Ukuchongwa kwe-HPLC | Ixesha logcino lwesampulu engundoqo liyahambelana noko |
Ukuchongwa kwe-IR | I-spectrum yokufunxa ye-infrared yesampulu ihambelana nesampulu yereferensi |
Indawo yokunyibilika | 214.0 ~ 222.0℃ |
Ilahleko ekomisweni | ≤0.50% |
Intsalela kwi-Ignition | ≤0.10% |
Iintsimbi ezinzima | ≤20ppm |
Izinto ezinxulumeneyo | (1) Ukungcola G: NMT 0.3% |
(2) Ukungcola B: NMT 0.3% | |
(3) Ukungcola C: NMT 0.3% | |
(4) Ukungcola D: NMT 0.3% | |
(5) Ukungcola A: NMT 0.3% | |
(6) Ukungcola H: NMT 0.3% | |
(7) Ukungcola F: NMT 0.3% | |
(8) Ukungcola E: NMT 0.3% | |
(9) Obona kungcola kukodwa: NMT0.1% | |
Izinyibilikisi ezishiyekileyo | (1) I-Ethyl Acetate: NMT 5000ppm |
(2) IMethanol: NMT3000ppm | |
(3) IDichloromethane: NMT 600ppm | |
(4) I-Ethanol: NMT 5000ppm | |
(5) iToluene: NMT 890ppm | |
(6) I-Dimethyl Sulfoxide: NMT5000ppm | |
Uvavanyo lwe-HPLC | 98.0% ~ 102.0% (C30H35N7SO4 Kubalwa kwi-Anhydrous Basis) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API;Ph+CML |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
I-Imatinib Mesylate (i-CAS 220127-57-1) i-molecule encinci inqanda i-c-Abl protein-tyrosine kinase, i-kinase ibaluleke ngokukodwa ekukhuliseni i-myelogenous leukemia engapheliyo (CML).Ngokucacileyo kakhulu kwi-BCR-ABL, i-enzyme ehambelana ne-myelogenous leukemia engapheliyo (CML) kunye neendlela ezithile ze-acute lymphoblastic leukemia (ALL).Inamandla kwaye ikhetha i-v-Abl tyrosine kinase inhibitor (IC50 = 38 nM).Isiganeko sokudluliselwa phakathi kwe-chromosomes 9 kunye ne-22 ivelisa i-chromosome yasePhiladelphia, ethi emva koko ivelise iprotheni ye-Bcr-Abl ye-fusion kunye nomsebenzi we-aberrant kinase okhuthaza ukwanda kweeseli ngokukhawuleza.I-Imatinib mesylate ibophelela le kinase ibalulekileyo, imisa ukukhula okunxulumene ne-CML.I-Imatinib mesylate iye yaphinda yaboniswa ukuvimbela i-PDGFR kunye ne-tyrosine kinases ehambelana ne-c-Kit.